-The Telegraph The Lokpal bill faces further delay with the Rajya Sabha today referring it to a 15-member select committee by voice vote, but not before the Opposition accused the government of playing “games” and trying to bypass House business rules. The select committee, to be made up by members from various parties, is to hand in its report by the last week of the monsoon session. The BJP, CPM and the Bahujan...

Muslim women may finally get their due share in family inheritance. The long standing demand of the All India Muslim Personal Law Board for a suitable amendment in the UP Zamindari Abolition and Land Reform Act 1950 to bring it at par with the Shariat is likely to get an official nod soon. After AIMPLB reasserted its stance last month, the state government is considering the option to push through...

Ambedkar is prophet to a people he created soul and politics for The recent controversy over the cartoon of Babasaheb Ambedkar sitting on a snail and Pandit Nehru whipping it from behind, indicating that Ambedkar had made the process of making the Constitution slow, whereas Nehru was for hastening it, created a massive ruckus in Parliament, cutting across all political parties. The cartoon, drawn by P. Shankar Pillai in 1949,...

Cabinet clears change in divorce law: Women to get part of husband’s property In a move that could be a setback to land acquisition for commercial use, a parliamentary committee unanimously recommended that the government should not acquire land for industrial, commercial or for-profit enterprises or private companies. Instead, the panel, which has proposed legislation favouring landowners, recommends that private companies and public-private partnerships would have to buy land in the open...

Health activists from across the country have asked the Union Health and Family Welfare Ministry to take immediate cognisance of the recent report of the Department Related Standing Committee that has criticised the functioning of the Central Drugs Standard Control Organisation (CDSCO) for irregular approvals for clinical trials and sale of medicines to pharmaceutical companies that put patients at risk. In a statement issued here on Wednesday, the activists asked the...